ATG4B and hepatocellular carcinoma: Furthermore, our results gain additional support from research showing berberine’s synergistic effects with other chemotherapeutic agents, such as its ability to increase the killing effect of pirarubicin on HCC cells by inhibiting the ATG4B-autophagy pathway [33].